Elevara Medicines

To add a bio or update company history, please click update information.

News from Elevara Medicines

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

22 Oct 2025

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

Elevara develops oral therapies for rheumatoid arthritis by targeting synovial fibroblasts rather than the immune system, aiming to improve remission rates in chronic inflammatory disease.

Elevara Medicines

Life Sciences
London, United Kingdom
£50m
elevara.com
Update Information

More venture news

Ternary Therapeutics
16 Mar 2026
Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines
SeedLife Sciences
BIOCAPTIVA
9 Mar 2026
BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy
EquityLife Sciences
LifeCellsNI
4 Mar 2026
LifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility
Pre-seedLife Sciences

Elevara Medicines

News from Elevara Medicines

Elevara raises £50m Series A led by Forbion and Sofinnova Partners to develop therapies for rheumatoid arthritis

More venture news

Ternary Therapeutics raises a £3.6m seed round led by daphni to engineer molecular glue medicines

BIOCAPTIVA secures £1.6m in funding led by Archangels for magnetic bead tech that prepares blood samples for liquid biopsy

LifeCellsNI secures £590k in pre-seed funding led by The AMP Angel Syndicate for regulated stem cell storage and biobanking facility